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 The Rhetoric of Scientific Discovery Accounts 
 
Carol Reeves 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
On April 23, 1984, Margaret Heckler, at that time the secretary of Health and 
Human services, announced at a press conference that "the probable cause of AIDS 
has been found." She went on to explain that the cause was a new virus and its 
discoverer was "our eminent Dr. Robert Gallo," chief of the National Cancer 
Institute (Crewdson 2). Gallo was known for his discovery of a family of human 
retroviruses ' -Human T-cell Leukemia Virus (HTLV)-that caused a rare form 
of cancer and had received the coveted Lasker prize, the top honor in American 
biomedicine which often precedes the Nobel Prize. In several papers published in 
1984, Gallo claimed to have found antibodies to what he believed was a new 
member of the Leukemia virus family-HTLV-III-in the blood serum of AIDS 
patients and that he had several isolates of the virus growing in his lab. He had also 
published electron micrographs of virus particles. On the day of Heckler's an- 
nouncement, the American biomedical community was ready to accept Gallo as 
the first to solve the mystery of AIDS etiology, was ready to view him as "one of 
the paradigmatic figures of the 20th Century"as Samuel Broder described him (in 
Crewdson). 
 
However, the Gallo lab was not alone in searching for the cause of AIDS and 
developing a blood test. At the time of Heckler's announcement,  the American 
patent office had two applications for a patent to the new AIDS blood test, the 
ELISSA (Enzyme-Linked Immuno-Absorbent Assay), one from the American 
Government and one from the Pasteur Institute in Paris. Gallo's chief rivals in the 
search for the cause of AIDS, a team headed by Luc Montagnier of the Pasteur 
Institute , had also applied for a patent on their ELISSA . They had argued at various 
conferences and in publications in 1983 and 1984 that they had found no antibodies 
to Gallo's leukemia virus in the blood of their AIDS patients, that the virus they 
had identified , Lymphadenopathy-Associated Virus, was unrelated to HTLV and 
that they had discovered it many months  before Gallo detected any retrovirus 
activity in blood samples from AIDS patients. Moreover, they were convinced that 
the American blood test had been made from the virus isolate the French had sent 
Gallo in the spirit of scientific collaboration. By 1985 a storm was brewing over 
who had first isolated the AIDS virus and who deserved the patent rights to the 
AIDS blood  test. In May  1985 the US patent  office issued a patent  to the US 
 
 
government on the ELISSA made with Gallo's AIDS virus. From May to Decem- 
ber 1985, representatives from the Pasteur Institute confronted senior officials at 
the Department of Health and Human Services (HHS) with evidence that they, not 
Gallo, had first isolated the virus and developed the ELISSA and that the American 
patent was invalid. The HHS rejected their claim. On December 12, 1985, the 
French filed suit against the US government. challenging the patent.2 
From 1985 to 1986, while the controversy surrounding the question of who 
first discovered the AIDS virus and developed the ELISSA heated up, Gallo 
published a flurry of review articles about research linking retroviruses to AIDS. 
Three of these five papers (Cancer, Cancer Research, and Scientific American ) 
were written by Robert C. Gallo alone; two of them ( The New England Journal of 
M edicine and Annals of Internal M edicine) were written by Gallo and a cowriter 
from his laboratory. In these accounts, Gallo and his cowriters use the review or 
discovery account genre to promote Gallo's role in AIDS research and his virus- 
  
HTLV-111-as the cause of AIDS. These five discovery accounts represent an 
intriguing opportunity to examine how one scientist and two members of his 
laboratory team demonstrate and attempt to maintain rhetorical authority during a 
period that represents a significant shift in knowledge about a devastating human 
problem. 
The necessity for rhetorical discourse during a shift in knowledge has been 
noted by several theorists. Sociologist Robert Merton notes that there is a rhetorical 
dimension involved when collectives compete to be the first to produce a public 
interpretation of a phenomenon and naturally want their interpretations to prevail 
over other interpretations (110-11). Likewise, Thomas Kuhn identifies rhetorical 
persuasion as essential to scientific revolutions: "To discover how scientific 
revolutions are effected, we shall therefore have to examine not only the impact 
of nature and of logic, but also the techniques of persuasive argumentation 
effective within the quite special groups that constitute the community of scien- 
tists" (Structure 94). It is impossible to determine here whether the discovery of 
retroviruses or the cause of AIDS had anything like the revolutionary impact upon 
whole scientific paradigms as did the identification of the double helix model of 
DNA. Nevertheless, the fact that these papers are directed at several different 
communities during a time when there was considerable competition for what 
Joseph Gusfield calls "ownership" of a public problem necessitates a close exami- 
nation of the strategies Gallo and his cowriters use to maintain that ownership. 
Gusfield explains that ownership "indicates the power to define and describe 
the problem" (13). People or institutions who "own" a public problem "can make 
claims and assertions. They are looked at and reported to by others anxious for 
definitions and solutions to the problem" (10). These papers demonstrate Gallo's 
determination to maintain  the privileges  of ownership-to be viewed  as the first 
to discover the cause of AIDS and to have the authority to name, define, and 
describe  the phenomenon  and control  its public  interpretation.  These accounts 
 
 
  
serve not only to disseminate knowledge but also to defend Gallo's primary role in 
generating that knowledge. 
Gallo claims "ownership" in AIDS research by crediting the divergent course 
his research has taken and his team's contributions to what is now routine labora- 
tory practice and by discrediting the early publications of the French team. Another 
way that Gallo gains rhetorical authority in these papers is to construct contexts 
that accommodate his intended audience's interests and beliefs. Gallo's readers 
range from biomedical specialists who read Cancer, Cancer Research, and Annals 
of Internal Medicine to medical practitioners who read The New England Journal 
of Medicine to a wider, perhaps less specialized, audience for the more popular 
publication, Scientific American. While there are obvious differences in the style 
and format of these papers due to editorial policy and convention, there are some 
contrasting features that I believe go beyond the necessities of convention and 
serve as flexible argumentative resources in Gallo's attempt to gain rhetorical 
ownership in AIDS research. Gallo demonstrates an acute understanding that 
different audiences have different epistemological assumptions and therefore need 
different conceptual constructions of the scientific enterprise as well as the phe- 
nomena under investigation. 
Steve Woolgar describes discovery accounts as reviews or "popular articles" 
that "present summary accounts of research" on a particular phenomenon (396). 
Woolgar finds a discrepancy between formal, published accounts and informal 
accounts gleaned from conversations and interviews. Published accounts "tended 
to give the impression of a relatively straightforward progression through a series 
of logical steps . . . leading to the discovery" (415) whereas personal interviews 
revealed that the discovery process is often marked by uncertainty, error, confu- 
sion, and surprise. In formal accounts, moreover, the debatable issues-such as the 
date of discovery, for example-are assumed to be closed and consensus achieved. 
Woolgar's findings imply  that the valedictory occasion for the formal accounts 
may require writers to give the impression that their discovery process was 
unproblematic and that the issues have been black-boxed. I am concerned here 
neither with comparing a scientist's formal and informal accounts nor with discov- 
ering whether Gallo's accounts are scientifically or historically accurate. My 
program is simply to identify the ways that Gallo uses the valedictory occasion as 
an active resource in an open battle for ownership in AIDS research. 
 
Crediting the Gallo Lab 
One way that Gallo establishes his "ownership" in AIDS research is to credit 
himself and his lab team and to discredit the French team. In two papers for which 
he was the sole writer, (Cancer and Cancer Research ) , Gallo emphasizes the role 
his lab played in retrovirus and AIDS research in the introductions. In the Scientific 
American, Annals, and New England Journal of Medicine , discussion of the primary 
role of the Gallo team appears in subsequent body paragraphs. Given the 
  
 
 
nature of the introductions to Scientific American and The New England Journal 
of Medicine, which emphasize the disease itself rather than the Gallo team's role 
in investigating the problem, it could be argued that staking territory in AIDS 
research for the benefit of his specialist peers in biomedicine is a high rhetorical 
priority for Gallo. Highlighting his lab's investigative role in AIDS research in the 
introductions to papers for specialists could be his way of tacitly reminding them 
of his ownership. 
In the introductions to the Cancer and Cancer Research papers, Gallo dis- 
cusses how the work done in his lab was the result of a readiness to travel outside 
mainstream cancer research and take an approach that differed from routine 
methodology. In Cancer, after he briefly summarizes the mainstream work on 
cellular one genes, he writes: 
 
However, these studies do not generally deal with primary causes. My 
co-workers and I are also interested in the molecular mechanisms 
involved in the pathogenesis of neoplasms, but our approach has been 
different. (2317) 
 
He then explains that his group has "focused on particular types of cells and 
particular forms of growth abnormalities" and that they "are also interested in the 
primary causes of these diseases" (2317). Also, he insists that he and his coworkers 
used the discoveries of others in ways that mainstream investigation did not. In 
both Cancer and Cancer Research, he describes how his lab creatively utilized the 
discovery of reverse transcriptase in ways the rest of the community did not. In 
Cancer, he writes that 
 
(w]hat stimulated us to work, rather than just to think about these 
questions, was the discovery of reverse transcriptase in retroviruses, 
which opened up new areas to molecular biology and paved the way 
to the understanding of the life cycle of these viruses. To us it also 
offered something more."(2317) 
 
In Cancer Research, he writes that "reverse transcriptase paved the way for the 
beginning of biochemical understanding of retrovirus replication . . . ; for me it 
was also a powerful and sensitive new tool for detecting low levels of retroviruses 
in human leukemias" (4524). Gallo knows the scientific community values the 
kind of flexible, divergent thinking that leads to the solution of major technical 
problems. Kuhn argues that the sciences "do demand just that flexibility and 
open-mindedness that characterize, or indeed define, the divergent thinker. . . . 
Unless many scientists possessed them to a marked degree, there would be no 
scientific revolutions and very little scientific advance" (fension 227). Whether or 
not Gallo's work was flexible and divergent is a question for sociologists. I am 
  
 
 
concerned here with how Gallo's introductions go further than the perfunctory 
assertion that the work about to be described represents a "significant advance" in 
knowledge . Gallo is doing more than building a context for the information he is 
about to provide. He is reminding his audience that his work represents a creative 
and divergent approach. 
Gallo also reminds his readers of  the skepticism and dogma that his team 
opposed. In Cancer Research he notes in the introduction that 
 
[o]ur idea that retroviruses might be present in small amounts in some 
human leukemias received considerable resistance . . . . Our premise 
was therefore contrary  to the experience and dogma current at that 
time, and our attempts were considered futile. (4524) 
 
Likewise, in the introduction to the Cancer paper, he writes that "when we set 
out to do these experiments, there were very strong doubts expressed by many 
investigators about the existence of any human retroviruses." Because these viruses 
had not been detected by electron microscopy, "it was assumed that no human 
retroviruses existed" (2317). 
In the midsection of the Scientific American paper, Gallo asserts that "the 
prologue to the discovery of the first human retrovirus is a history of skepticism" 
(88), and later, he places himself in the position of countering common wisdom: 
 
Under the influence of Termin 's ideas I decided to search for reverse 
transcriptase in human leukemic cells, hoping to find a retrovirus there. 
In so doing, I was gainsaying acceptable wisdom. (91) 
 
The premise evoked in these examples is that it is often necessary to consider 
the impossible, to go outside mainstream assumptions and dogma in order to conduct 
research having an impact on the growth of scientific knowledge . He is implying 
that without his willingness to consider the possibility of a human retrovirus science 
would be without the benefits resulting from such efforts, namely the information 
about the relationship among human retroviruses, T-cell leukemia , and acquired 
immunodeficiency. Though it is uncertain whether retrovi- rology had a 
revolutionary impact on whole paradigms within several scientific communities, it 
is clear that Gallo wants his audience to think of his work as having a singularly 
important impact. 
While he refers to other laboratory teams doing research on retroviruses and 
AIDS, Gallo insists that by being the first to ask that all important initial question 
about the role of retroviruses in AIDS and by developing technology with which 
to isolate the virus, his lab actually reached "the top" first. Though he gives credit 
to the collaborative efforts of labs across the country, his references to his chief 
competitors, the Pasteur Institute team, who first published findings of isolation of 
  
 
 
retroviruses from AIDS patients, traverses a fine line between credit and discredit: 
He concedes that they were the first to publish findings of retrovirus activity in 
AIDS patients, but dismisses those findings as "inconclusive." In so doing, Gallo 
discredits the work of the French team and their claim that the AIDS virus is a 
newly discovered virus unrelated to Gallo's HTLV. 
According to Gallo, the obstacles involved in growing and propagating the 
virus prevented the French team from definitively characterizing the virus, and, in 
effect, from actually being "the first," to make the discovery. In the Annals paper, 
just after they establish that the problem of losing virus isolates "initially prevented 
characterization of the virus, development of specific reagents and clear-cut linkage 
of the virus to the cause of AIDS," Gallo and Wang-Staal write, "However, in 1983, 
the group at the Pasteur Institute headed by Luc Montagnier reported their first 
description of the virus associated with AIDS. . . . These investigators also had 
difficulty in getting adequate amounts of this virus to grow; they could not keep 
the primary cells in culture indefinitely . . . . Therefore, the virus was not 
characterized, nor clearly linked to the cause of AIDS in 1983, and specific reagents 
for the virus could not be developed" (683). 
In Cancer Research, he explains  that  the French  team  could "not report 
evidence indicating that any two isolates [of the virus] were the same" but published 
their findings anyway because they were "sufficiently convinced of its interest to 
publish the first identification of the virus" (4528). However, as Gallo points out, 
his team had also isolated the virus, but rather than publish prematurely , they decided 
to wait because they "did not feel these results were sufficiently clear to publish at 
that time" (4528). In explaining that his team did not publish their findings until 
they had found a way to grow the virus and thus definitively characterize it, Gallo 
obviously wants to demonstrate that although the other team might have reached the 
top first, they took a short cut. Gallo implies that the other team lacked the patience 
and tenacity that contributed to the conclusive work done in his lab. 
In addition to reminding his audience that the French team's first published 
data were inconclusive, Gallo also reminds his readers that he and his colleagues 
first proposed the notion that AIDS was caused by a retrovirus and thereby initiated 
investigation of that hypothesis. In the Cancer Research paper, he states, "I 
proposed that AIDS was likely to be caused by a human T-lymphotropic retrovirus 
in February, 1982 at a Cold Spring Harbor Conference on AIDS" (4527). Likewise, 
in Cancer, he writes that "[w]e reasoned that AIDS was a viral disease and 
proposed that it was due to a human T-lymphotropic retrovirus in February 1982 
at a Cold Springs Harbor Meeting on AIDS" (2321). He and Wong-Staal remind 
their readers in the Annals paper, that "the genes of HTLV-III were first molecu- 
larly cloned in our laboratory" (684). Like the explorers who mark their territory 
with a flag and want the world to acknowledge their symbolic ownership of a place, 
  
 
 
Gallo wants the scientific community to acknowledge his ownership of the terri- 
tory of AIDS research. 
Gallo also promotes his work as resulting in the kind of new knowledge and 
technology which initiates major shifts in methodology. In all his accounts, Gallo 
describes the technology and methods developed in his lab that enabled investiga- 
tors to first identify human retroviruses and then to isolate the retrovirus causing 
AIDS. He also reminds readers that these methods have become indispensable to 
routine practice. In the introduction to the Cancer paper, for example, he points 
out that his discovery of T-cell growth factor or interleukin-2 and the techniques 
he and his lab team developed to use interleukin-2 to stimulate T-cell growth in 
vitro "became the approach to isolate human retroviruses." Moreover, he reminds 
his readers that "selection of the right patient, use of sensitive assays for virus, and 
proper growth of the cells in vitro has made isolation of these viruses now a 
routine" (2318). It is important to keep in mind that there is no clinical necessity 
for descriptions of these methods since they have become so much a part of 
routine; however, rhetorical necessity requires that Gallo remind his audience of 
what team is responsible for developing these methods. 
Gallo's emphasis on the role his work played in the discovery of the cause of 
AIDS likely undergirded his claim that his virus, HTLV-III, was the cause of AIDS 
and helped to market him as an "owner" in AIDS research . In all the papers, the 
claim that HTLV-III causes AIDS and that it is the same virus isolated by other 
researchers seems unproblematic , black-boxed. In the New England Journal of 
M edicine, for example, while he concedes that "there is a noteworthy diversity in 
the . . . patterns seen among HTLV-III isolates from different patients," he still 
claims that the French LAV is not another virus but one of the forms of HTLV-III: 
". . . we believe that HTLV-III really represents a set of closely related but varying 
genetic forms, and that lymphadenopathy-associated virus [LAV] is one of these 
forms" (1295). 
In the Annals paper, Gallo and Wong-Staal enumerate the evidence pointing 
to HTLV-III as "clearly" the cause of AIDS: 
 
There are now more than 100 isolates of HTLV-III in our laboratory. 
The virus was isolated from all risk groups: homosexuals, drug abus- 
ers, blood product recipients, mothers and fathers of infected children, 
promiscuous heterosexual men, prostitutes, Haitians, and the wives of 
men with AIDS. We have never been able to detect the virus in a 
normal donor. Thesefindings alone clearly link the virus to the cause 
of AIDS. (684, emphasis mine) 
 
In their classification of statement types, Latour and Woolgar define a claim 
as a statement which contains "modalities which draw attention to the generality 
of available evidence (or lack of it)" (79). The modality "clearly" draws attention 
  
 
 
away from what could be problematic in Gallo's claim. Other labs had reported 
isolations of retroviruses from AIDS patients, but no one had confirmed that these 
isolates represented the same virus or that they were all isolates of Gallo's retrovirus. 
In fact, a research report written by Luc Montagnier follows the Gallo and Wong-
Staal paper in Annals. Montagnier claims that the primary causative agent of the 
acquired immunodeficiency syndrome "is a type of retrovirus that has not been 
previously recognized" (689). At least as far as the French were con- cerned, 
consensus had not reached the point that a definitive statement about the link 
between HTLV and AIDS was even possible. Yet Gallo's ostensibly unprob- 
lematic statement is made after he has narrated the history of research on retrovi- 
ruses and AIDS and made himself and his lab team chief protagonists in that story. 
By establishing the primary role of his lab in AIDS research, Gallo lends credibility 
to his claim that his virus is the virus causing AIDS. 
 
Building Contexts 
Another way that Gallo gains rhetorical authority in these papers is to con- 
struct contexts that accommodate his intended audience's interests and beliefs. In 
his introductions and conclusions, he focuses on issues indicative of his intended 
audience's assumptions about such matters as AIDS, science, and knowledge. 
The main contextual difference between Gallo's introductions in Cancer 
Research and Cancer and his introductions in The New England Journal of 
Medicine and Scientific American centers around the issue of agency. For special- 
ists, Gallo emphasizes his laboratory team's agency in AIDS research, an emphasis 
that accommodates the communal ritual of identifying the discoverer and the belief 
that such an endeavor is even possible given the collaboration that occurs in science. 
For readers of The New England Journal of Medicine and Scientific American, 
however, Gallo emphasizes the disease itself as an agent in causing human 
suffering and public catastrophe and then counters the grim outlook with the 
consolation of new knowledge. 
In the NEJM paper, Gallo and Broder demonstrate a clear intent to communi- 
cate with those who will actually treat AIDS patients in their office or emergency 
rooms. Throughout the paper the authors counter the bad news-the devastating 
and frustrating course of the new disease-with the good news-the growing 
knowledge about AIDS and the medical benefits that might be reaped from this 
knowledge. In the introduction they claim that "one of the major frustrations for 
practicing physicians and the public alike has been the inability of the scientific 
community to define the origin of this disease" (1292). They liken this frustration 
to the sentiments expressed by John Donne: "Perhaps John Donne, in 1624, in 
reference to his own life-threatening illness,  was able to capture some of the 
frustrating emotions felt by patients with AIDS, persons thought to be at risk of 
AIDS, and their physicians" (1292). They then quote Donne: 
  
 
'I observe the Phisician, with the same diligence, as hee the disease; I 
see hee feares, and I feare with him, I overrun him in his feare, and I 
go the faster, because he makes his path slow; I feare the more, because 
he disguises his fear, and I see it with more sharpnesse, because hee 
would not have me see it.' (l292) 
 
The reference to the frustrations felt by patients and doctors alike and the Donne 
quote embody the text with a highly personal tone. The writers establish an 
intimate relationship with their readers as members of the practitioner commu- 
nity-a membership of individuals who have witnessed the AIDS epidemic first 
hand. Gallo and Broder want their readers to know they understand the plight of 
the practitioner facing patients who have a debilitating and overwhelming disease. 
But they also want to console their readers with the hope of new knowledge about 
the cause of the disease, as they say in their introduction : 
 
But recently, several converging lines of research have linked a 
human T-cell lymphotropic retrovirus (HTLV-III) to the pathogenesis 
of AIDS, and this knowledge has brought us closer to understanding 
the disease. (1292) 
 
In the introduction to the paper in Scientific American, Gallo employs meta- 
phors that Susan Sontag has identified in the language of AIDS, the metaphors of 
plague and apocalypse. Gallo's first sentence contains the plague metaphor: "It is 
a modem plague: the first great pandemic of the second half of the 20th Century" 
(47). Sontag says that plague "has long been used metaphorically as the highest 
standard of collective calamity, evil, scourge" (89). Gallo goes on to add that "by 
now as many as two million people in the U.S. may be infected" and that "in some 
areas it may be too late to prevent a disturbingly high number of people  from 
dying" (47). The "bad news" outlined in the first paragraph is followed by the 
"good news" outlined in the second:"In sharp contrast to the bleak epidemiologi- 
cal picture of AIDS, the accumulation of knowledge about its cause has been 
remarkably quick. Only three years after the disease was described its cause was 
conclusively shown to be the third human retrovirus" (47). In this introduction 
Gallo accommodates his readers by evoking the metaphors they likely associate 
with AIDS and by reassuring them that though infection has reached catastrophic 
proportions, the disease is no longer shrouded in mystery . Gallo allows himself 
some dramatic touches that would not be appropriate for more specialized audi- 
ences. 
In the conclusions to the papers in Annals, CanCfI , Cancer Research , and The 
N ew England Journal of Medicine, Gallo appeals to the premise that scientific 
explanation of puzzling phenomena is always a desirable end in itself. Though, as 
Gallo  points  out,  the  retrovirus  may  pose  serious  psychological  and  physical 
  
 
 
problems for its victims, it  is a "remarkable" biological entity for scientists to 
study. Moreover, he  explains that not only has  research identified the  human 
retrovirus causing AIDS but also promises to curtail its destructive capacity. The 
consolation of new knowledge about AIDS is placed against the morbidity and 
mortality caused by AIDS. 
He concludes the Cancer and Cancer Research papers by reminding his readers 
of the optimistic results of the contributions he outlined in the introductions and 
throughout the papers. In concluding the Cancer paper, he avoids mentioning the 
clinical difficulties involved in disease management and vaccine development for 
a virus that has a great capacity to mutate and states that "preventive measures to 
control the spread  of AIDS with the help  of chemotherapeutic agents or a vaccine 
are currently being actively pursued" (2321). He ends the paper by reminding his 
readers of the rapid progress in research: 
 
Thus, in the past 5 years, the first human retroviruses have been 
discovered and two types have been linked to the cause of two different 
human diseases. (2321) 
 
He also reminds readers of the interesting knowledge that has been discovered: 
 
Remarkably, one disease involves an over-proliferation of the T4 
lymphocyte, while the other involves premature death of the same cell. 
(2321) 
 
Finally, he alludes to the technological innovations developed in his laboratory and 
their effects on basic research: 
 
The capacity to mimic the disease in vitro by infecting target normal 
T4 cells provides the most powerful system available for the study of 
altered growth of a human cell. (2321) 
 
In concluding the Cancer Research paper, Gallo says: 
 
The past 5  years have witnessed the beginning of a new era in 
retrovirology, the era of human retroviruses. Within this short period 
the causes of two human fatal diseases have been worked out. In both 
instances in vitro systems have developed which mimic the diseases 
so that a reasonable amount of information on the involved molecular 
mechanisms has become available. The future promises much more 
such information , but what is much less certain is how soon we will 
learn to correct and/or prevent these diseases. (4530) 
  
 
 
Though this statement is not wholly optimistic, it is important to note that Gallo 
does not ask whether we will learn to prevent these diseases but how soon. 
In The New England Journal of Medicine, after detailing the new knowledge 
about retroviruses and about the history of their discovery, the writers conclude the 
paper by enumerating what they believe is optimistic about their findings. Knowl- 
edge of the virus "may affect many phases of basic research with clinical implica- 
tions" (1295): "a stimulus to re-examine endemic forms of cancer that pose special 
public-health problems for some nations in the Third World" and the possibility of 
developing "a vaccine for persons who belong to certain risk groups and thereby 
prevent the disease" (1296). Whereas he emphasizes the implications for future 
research at the end of the specialized research journals, here Gallo and Broder 
emphasize the implications for treatment of serious medical problems caused by 
the virus. 
In the Scientific American, he concludes by painting a very different picture 
of the scientific community. Gallo warns his readers of the "hubris" of scientists 
in thinking that infectious disease has been conquered. In the final paragraph, Gallo 
discusses the "moral" of "this terrible tale." He says that the discovery of retrovi- 
ruses and their "capacity to cause extraordinarily complex and devastating disease 
has exposed the claim [that science has conquered infectious disease] for what it 
was:hubris. Nature is never truly conquered" (65). It is interesting that he ventures 
a moral attack on the "hubris" of modern science in this paper while in the other 
papers he applauds the capacity of basic science to explain puzzling phenomena 
and develop new technology. 
In light of the recent negative publicity surrounding Gallo, it would seem 
prima facie that Gallo was using base rhetoric, was playing to the gallery. However, 
a more benign interpretation is that Gallo was using two contrasting conceptions 
of science as flexible tools for arguing in different contexts. Karl Popper suggests 
that the primary aim of science is "to find satisfactory explanations of whatever 
strikes us as being in need of explanation" and that ". . . scientific explanation, 
whenever it is a discovery, will be the explanation of the known by the unknown" 
(191). For scientific culture, explanation of puzzling phenomena , rather than 
control of phenomena, is a desirable end in itself. In popular culture, the Franken- 
stein or mad scientist myth, as well as such highly publicized cases as the 
development of the atom bomb and human genetic engineering, combine to build 
a popular image of science as aiming to control nature with often disastrous 
consequences. The discrepancy between Gallo's celebration of scientific explana- 
tion in Cancer and Cancer Research and his admonishment of scientific hubris in 
Scientific American would seem hypocritical to a positivist but merely ironic to 
anyone who understands the relationship between rhetoric, culture, and reality. 
  
 
 
Will the Real Virus Please Stand Up? 
Description of the phenomenon itself offers another flexible argumentative 
resource for Gallo. Rhetorical ownership implies the authority to name, define, and 
describe the phenomenon and control its public interpretation. Gallo's descriptions 
of the AIDS virus itself indicate his sensitivity to the needs and expectations of his 
specialized and lay audiences as well as his understanding that his descriptions 
influence their perceptions of the virus and his role in its discovery. In these 
descriptions two metaphorical conceptions of the virus construct two very different 
public interpretations of the disease. 
Jeanne Fahnestock has traced the "rhetorical life" of scientific facts ( 1986) as 
they move from specialized to lay publications . Fahnestock illuminates the ways 
journalists inscribe scientific findings in language that is more certain and authori- 
tative than the language in scientific research reports and how the translation from 
scientific to lay communication belies the different epistemological assumptions 
and rhetorical practices of both communities . But what happens when one writer 
or one team of writers disseminates new knowledge and the story behind its 
discovery to different audiences, to specialized and unspecialized readers? 
The star of the show, the AIDS virus itself, offers an interesting view of the 
way one writer or a team of writers may very subtly "change" the phenomenon at 
hand to accommodate different audiences. In both the Annals and the Scientific 
American papers, the virus and its cytopathic effects are described  in detail, but 
both descriptions offer different conceptions of the virus. In the Annals paper, the 
human retrovirus causing AIDS is a "remarkable" natural phenomenon with 
"unique" biological capacities. In the Scientific American , the virus becomes an 
"invader," a "culprit" that violently attacks its host. Although Gallo cowrote the 
Annals paper with Wong-Staal and although it is impossible to tell which writer 
composed the descriptions of the virus, the difference in the language used to 
describe retrovirus activity in these two papers indicates the different needs and 
attitudes of the two audiences. The biomedical specialist is interested in the virus 
as a clinical entity and needs to know how the virus differs from other viruses. The 
Scientific American readers likely knew the virus not as a clinical entity but as a 
killer; Gallo's descriptions of the virus accommodate their expectations and allow 
them to visualize and imagine intercellular activities. 
For readers of Annals, Gallo and Wong-Staal choose terms which depict the 
virus as "agent" and the host cell as "scene" but do not necessarily invoke visual 
images of aggression: 
 
This enzyme [reverse transcriptase] converts viral RNA into double 
stranded DNA. For virtually all retroviruses, the DNA form moves 
from the cytoplasm to the nucleus where it integrates into the host cell 
DNA. (679, emphasis mine) 
  
 
In contrast, the description  of the same activity in Scientific American uses 
stronger verbs connoting aggressive agency: 
 
When the virus enters its host cell, a viral enzyme called reverse 
transcriptase exploits the viral RNA as a template to assemble a 
corresponding molecule of DNA. The DNA travels to the cell nucleus 
and inserts itself among the host's chromosomes, where it provides the 
basis for viral replication. (47, emphasis mine) 
 
In describing this activity, Gallo is sensitive to his nonspecialized readers' 
need for more graphic visual images to help them imagine what they will probably 
never get the chance to see. The key differences are in the verbs: "converts" becomes 
"exploits," "moves" becomes "travels," and "integrates" becomes "in- serts itself." 
The first set of verbs implies that what is occurring is a process in nature, a 
complex relationship between viruses and human T-cells. But the second set of terms 
builds a metaphoric theme centered on the retrovirus as an aggressive invader, a 
model likely to be recognized by his readers. 
Mary Hess explains how metaphor works in scientific knowledge: 
 
. . . metaphor works by transforming the associated ideas and implica- 
tions of the secondary [which involves language] to the primary 
[involving observation] system. These select, emphasize, or suppress 
features of the primary [which]. . . is 'seen through' the frame of the 
secondary. (l 14) 
 
In other words, through language we provide versions of the empirical world . The 
version of retrovirus activity in the paper for virologists suppresses features of 
aggression while his version prepared for unspecialized readers emphasizes these 
features. 
Descriptions of how the virus transforms cells and infiltrates the bloodstream 
are also different. In Annals the writers explain that once infection occurs, 
 
integrated viral genes are duplicated with the normal cellular genes so 
all progeny of the originally infected cell will contain the viral genes. 
The cell may become a cancer cell by the expression of one or more 
viral genes. In  other instances, integration of the viral DNA form 
without expression of the viral genes may lead to a change in the 
expression of nearby cellular genes, leading to the pathologic effects 
of the virus. (679) 
 
In Scientific American the story goes like this: Once infection occurs, and the T4 
cells gets activated, 
  
 
 
instead of yielding  1,000 progeny [as is a healthy system] the infected 
T cell proliferates into a stunted clone with perhaps as few as 10 
members. When those 10 reach the blood stream and are stimulated 
by antigen, they begin producing virus and die. (50) 
 
Obviously, Gallo constructed the second account so that visual imagery might 
accommodate the unspecialized reader and the context of a more "popular" 
publication. We can "see" the "stunted clone" and imagine the pathetic army of 
only ten fighters entering the blood stream, unaware that they carry within them- 
selves the very enemy they seek. 
In the Annals  paper, Gallo seems intent on bringing  the uniqueness of the 
HTLV family of viruses to light. This uniqueness is defined in terms of such things 
as the "indirect association  with B-cell leukemia and lymphoma," and "a trans- 
acting transcriptional  activation  of viral  long terminal  repeat sequences" (686). 
Gallo explicitly labels these and other features as "unique family traits." Thus, in 
this paper, Gallo is concerned with showing how the human retroviruses differ 
from other viruses in their biological , biochemical, and epidemiologic uniqueness. 
The retrovirus' uniqueness in comparison with other viruses plays a lesser role 
in the Scientific American paper. It is more important to gain the readers' under- 
standing by helping them visualize through language of destruction and violence . 
Gallo depicts the retrovirus as a furious, violent agent that plays havoc with T4 
cells: 
 
The virus bursts into action, reproducing itself so furiously that the 
new virus particles escaping from the cell riddle the cellular membrane 
with holes and the lymphocyte dies. (49) 
 
We may well imagine Audie Murphy bursting from a blown-up tank and riddling 
the German invaders with bullet holes. 
Gallo proposes a hypothetical model, as he calls it, of the process of cell death: 
 
[the cell's] death may depend on an interaction between the viral 
envelope and the cell membrane. Perhaps that interaction . . . punches 
a hole in the membrane. Because the virus buds in a mass of particles, 
the cell cannot repair the holes as fast as they are made; its contents 
leak out and it dies. (52) 
 
The above description, "for the moment only a model" employs an analogy from 
our everyday experience. Terms such as "punch out" and "leaks out" suggest a 
visual model of puncturing a hole in a bag full of water. This modeling is actually 
both an hypothesis and a tool for explanation . 
  
 
 
It is physically impossible for  Gallo to directly observe the mechanisms 
contributing to cell death; thus Gallo employs analogy as a heuristic device for his 
own problem solving. This analogy also serves rhetorical purposes. The vivid and 
graphic qualities of his description enable the reader not only to visualize a 
biochemical process but also to picture a battleground which scientists like Gallo 
have spent countless hours investigating. Gallo wants the readers of Scientific 
American to know the formidable odds in fighting such an enemy and to under- 
stand that "the progress made in only three years" (55) represents the fruits of the 
valid scientific investigation done in his lab. 
Given the exigencies that could have contributed to the rhetorical situation- 
the lawsuit against Gallo's patent claim as well as the laboratory evidence that the 
virus isolated by the French was unrelated to HTLV-we can assume that these 
papers represent Gallo's attempt to reclaim rhetorical ownership in AIDS research, 
to reassert the primary role of his laboratory in discovering human retroviruses and 
linking them to AIDS. However, I believe these accounts represent something 
more than one scientist's attempts to gain rhetorical ownership. These accounts 
actually tell us more about the social forces surrounding the acceptance of a theory 
than about the actual real world of the laboratory. Steve Woolgar has argued that 
"the practical expression of, or reference to, a phenomenon both recreates and 
establishes anew the existence of the phenomenon . In describing a phenomenon, 
participants [that is, writers and readers] simultaneously render its out-there-ness" 
(246). Gallo's depiction of the virus itself recreates the phenomenon, the retrovirus, 
which is a different critter for different audiences. And his depiction of his lab's 
role in human retrovirology and AIDS research not only recreates that role but 
rekindles communal expectations about the kind of laboratory investigation that 
leads to significant discoveries. Though certainly more research of the discovery 
account genre is needed before we can draw definitive conclusions about them, I 
suggest that discovery accounts, a recognized form of valedictory address which 
usually occurs after a community has settled issues and reached consensus, may 
actually be employed by writers to settle those issues and establish their rhetorical 
ownership in the field. Gallo adopts the discourse appropriate for a closed debate 
as an active argumentative resource in an open battle. 
 
 
Notes 
1According to Gallo, "A retroviru s carries within its core an enzyme that synthesizes DNA, reverse 
transcriptase. This enzyme converts viral RNA into double stranded DNA . For virtually all retroviruses , 
the DNA form moves from the cytoplasm to the nucleus where it integrates into the host cell DNA" 
(Annals 679). 
2For a thorough account of the controversy between Gallo and the French, see "Science Under the 
Microscope" by John Crewdson. The Chicago Tribune, November 18, 1989. 
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